Oncotarget, being founded in 2010, a well-known traditional multidisciplinary journal. It’s actually the world’s largest oncology journal in existence currently.
With open access being one of Oncotarget’s core values that it even has Creative Commons Attribution 3.0 License.
Of course, there are other associated studies that Oncotarget is also focused around besides just oncology such as gerotargeting and also immunology.
Because of Oncotarget’s open access nature, journals are much more easily accessible tor the results to be shared more easily. The reason for this approach is allow the Oncotarget to treat cancer in a much, more faster rate.
The goal that is associated with this is to use journals to fight disease in a more effective manner.
Through this, Oncotarget can easily team up with recognized scientific indexes.
Another benefit is that the journal records and saves each and every study that is placed in the study. Learn more about Oncotarget at Research Gate.
Oncotarget has been involved with many achievements that are undeniable.
One particular achievement that Oncotarget is pleased in sharing is that this journal and its researchers have been able to identify new therapeutic strategics to treat thyroid cancer.
Oncotarget can still be found in the following scientific databases such as BIOSIS Previews, Scopus, Embase, and Biological Abstracts.
Oncotarget New Media Achievements
Oncotarget also has been making rather forward achievements, in regards to their objectives for their media platform.
The foremost achievement is that Oncotarget has successfully been able to increase its frequency into a twice-weekly publication.
The second achievement is that Oncotarget has created its own podcast that details its findings in podcasting format. The episodes are fairly short but these episodes are fairly easy to listen to directly. Follow Oncotarget journal on Twitter.
The podcast is available on Stitcher, Soundcloud, Player.FM, and iTunes.
Appreciaton for Oncotarget
This journal is actually making a wonderful difference in the world of oncology, especially with its focus on preventing cancer in the lives of paitents.
If there’s one factor that is easily to be noticed how much cancer can affect the lives of the patients and the claustrophobic sense of doom that everyone can feel in those situations.
However, with the help with Oncotarget, people can be able to prevent a life-changing disease to people at very inopportune times.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/